Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animalsJapanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon. Shares of Anges were untraded with a glut of buy orders in early morning. There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called COVID-19.
Source: bd News24 March 24, 2020 12:23 UTC